Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?
Pulsipher MA, Langholz B, Wall DA, Schultz KR, Bunin N, Carroll W, Raetz E, Gardner S, Goyal RK, Gastier-Foster J, Borowitz M, Teachey D, Grupp SA. Pulsipher MA, et al. Among authors: raetz e. Bone Marrow Transplant. 2015 Sep;50(9):1173-9. doi: 10.1038/bmt.2015.103. Epub 2015 May 11. Bone Marrow Transplant. 2015. PMID: 25961775 Free PMC article. Clinical Trial.
Using fluorescence-activated cell sorting followed by fluorescence in situ hybridization to study lineage relationships: the 8;21 translocation is present in neutrophils but not monocytes in a patient with severe congenital neutropenia and a granulocyte colony-stimulating factor-responsive clonal abnormality.
White C, Chen Z, Raetz E, Pulsipher M, Spangrude GJ, Slayton WB. White C, et al. Among authors: raetz e. Acta Paediatr Suppl. 2002;91(438):120-3. doi: 10.1111/j.1651-2227.2002.tb02916.x. Acta Paediatr Suppl. 2002. PMID: 12477275
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.
Pulsipher MA, Langholz B, Wall DA, Schultz KR, Bunin N, Carroll WL, Raetz E, Gardner S, Gastier-Foster JM, Howrie D, Goyal RK, Douglas JG, Borowitz M, Barnes Y, Teachey DT, Taylor C, Grupp SA. Pulsipher MA, et al. Among authors: raetz e. Blood. 2014 Mar 27;123(13):2017-25. doi: 10.1182/blood-2013-10-534297. Epub 2014 Feb 4. Blood. 2014. PMID: 24497539 Free PMC article. Clinical Trial.
Classification of treatment-related mortality in children with cancer: a systematic assessment.
Alexander S, Pole JD, Gibson P, Lee M, Hesser T, Chi SN, Dvorak CC, Fisher B, Hasle H, Kanerva J, Möricke A, Phillips B, Raetz E, Rodriguez-Galindo C, Samarasinghe S, Schmiegelow K, Tissing W, Lehrnbecher T, Sung L; International Pediatric Oncology Mortality Classification Group. Alexander S, et al. Among authors: raetz e. Lancet Oncol. 2015 Dec;16(16):e604-10. doi: 10.1016/S1470-2045(15)00197-7. Lancet Oncol. 2015. PMID: 26678213 Review.
How is the Ph-like signature being incorporated into ALL therapy?
Maese L, Tasian SK, Raetz EA. Maese L, et al. Best Pract Res Clin Haematol. 2017 Sep;30(3):222-228. doi: 10.1016/j.beha.2017.06.001. Epub 2017 Jun 15. Best Pract Res Clin Haematol. 2017. PMID: 29050695 Free PMC article. Review.
225 results